ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994

Anonymous $100 Million Gift Moves OHSU Within $82 Million Of Reaching $1 Billion Goal

August 1, 2014

Cancer Control Budget Still $4 Million Short

January 28, 1977

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.”

October 21, 2005